Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AbbVie agrees to acquire ImmunoGen for around $10.1bn
The deal will see ImmunoGen’s follow-on pipeline of next-generation ADCs complement the ADC platform and current programmes of AbbVie. Credit: Photo by Volodymyr Hryshchenko on Unsplash.
The deal will see ImmunoGen’s follow-on pipeline of next-generation ADCs complement the ADC platform and current programmes of AbbVie. Credit: Photo by Volodymyr Hryshchenko on Unsplash.